Literature DB >> 10686126

Evidence for altered Fragile-X mental retardation protein expression in response to behavioral stimulation.

S A Irwin1, R A Swain, C A Christmon, A Chakravarti, I J Weiler, W T Greenough.   

Abstract

The Fragile-X mental retardation protein, the protein absent in Fragile-X syndrome, is synthesized near synapses upon neurotransmitter activation. Humans and mice lacking this protein exhibit abnormal dendritic spine lengths and numbers. Here we investigated Fragile-X protein levels in animals exposed to behavioral paradigms that induce neuronal morphological change. Fragile-X protein immunoreactivity was examined in visual cortices of rats reared in a complex environment for 10 or 20 days, motor cortices of rats trained on motor-skill tasks for 3 or 7 days, and either visual or motor cortices of inactive controls. Rats exposed to a complex environment for 20 days or trained for 7 days on motor-skill tasks exhibited increased Fragile-X protein immunoreactivity in visual or motor cortices, respectively. These results provide the first evidence for a behaviorally induced alteration of Fragile-X protein expression and are compatible with previous findings suggesting synaptic regulation of its expression. These results also strengthen the association of Fragile-X mental retardation protein expression with the alteration of synaptic structure. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686126     DOI: 10.1006/nlme.1999.3914

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  11 in total

Review 1.  The fragile X mental retardation protein in circadian rhythmicity and memory consolidation.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Mol Neurobiol       Date:  2009-02-12       Impact factor: 5.590

Review 2.  Synaptic regulation of protein synthesis and the fragile X protein.

Authors:  W T Greenough; A Y Klintsova; S A Irwin; R Galvez; K E Bates; I J Weiler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  Developmental disorders of activity dependent neuronal plasticity.

Authors:  M V Johnston
Journal:  Indian J Pediatr       Date:  2001-05       Impact factor: 1.967

4.  Neuronal activity drives FMRP- and HSPG-dependent matrix metalloproteinase function required for rapid synaptogenesis.

Authors:  Mary L Dear; Jarrod Shilts; Kendal Broadie
Journal:  Sci Signal       Date:  2017-11-07       Impact factor: 8.192

5.  Autism spectrum phenotype in males and females with fragile X full mutation and premutation.

Authors:  Sally Clifford; Cheryl Dissanayake; Quang M Bui; Richard Huggins; Annette K Taylor; Danuta Z Loesch
Journal:  J Autism Dev Disord       Date:  2007-04

6.  Drosophila fragile X mental retardation protein developmentally regulates activity-dependent axon pruning.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Development       Date:  2008-03-05       Impact factor: 6.868

7.  Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses.

Authors:  Ivan Jeanne Weiler; Chad C Spangler; Anna Y Klintsova; Aaron W Grossman; Soong Ho Kim; Valerie Bertaina-Anglade; Hooma Khaliq; Froukje E de Vries; Femke A E Lambers; Fatima Hatia; Christine K Base; William T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-17       Impact factor: 11.205

8.  Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Front Synaptic Neurosci       Date:  2010-06-07

9.  Deletion of Fmr1 alters function and synaptic inputs in the auditory brainstem.

Authors:  Sarah E Rotschafer; Sonya Marshak; Karina S Cramer
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

10.  Enriched environment promotes behavioral and morphological recovery in a mouse model for the fragile X syndrome.

Authors:  Leonardo Restivo; Francesca Ferrari; Enrica Passino; Carmelo Sgobio; Jörg Bock; Ben A Oostra; Claudia Bagni; Martine Ammassari-Teule
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.